Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases
- 1 November 2002
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (17) , 2258-2264
- https://doi.org/10.1016/s0959-8049(02)00234-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Analysis of key cell‐cycle checkpoint proteins in colorectal tumoursThe Journal of Pathology, 2002
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast CancerJournal of Clinical Oncology, 2001
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Therapeutic opportunities from tumour biology in metastatic colon cancerEuropean Journal Of Cancer, 2000
- Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and proα2 (1) collagen (COL1A2)Human Molecular Genetics, 1992
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- Increased Expression of the Epidermal Growth Factor Receptor on Human Colon Carcinoma CellsArchives of Surgery, 1986